secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2026-06-29T20:30:40+00:00
Accession:  0001386570-26-000035
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Niagen Bioscience announces 2026 annual meeting voting results; all directors elected
--------------------------------------------------------------------------------

- All 8 director nominees elected: Rubin (28.5M for, 16.8M withheld) and Shahbazi (30.5M for, 14.7M withheld) had significant withhold votes.
- Ratification of Crowe LLP as auditor for fiscal 2026 passed with 56.2M for, 2.3M against, 158k abstain.
- Advisory say-on-pay proposal approved with 43.2M for, 1.9M against, 172k abstain, and 13.3M broker non-votes.
- Broker non-votes of 13.3M were recorded on director elections and say-on-pay but not on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000035/0001386570-26-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000035/cdxc-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001386570-26-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer